Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Cortical thinning across Parkinson's disease stages and clinical correlates.

Wilson H, Niccolini F, Pellicano C, Politis M.

J Neurol Sci. 2019 Jan 17;398:31-38. doi: 10.1016/j.jns.2019.01.020. [Epub ahead of print]

PMID:
30682518
2.

Microbiological surveillance of flexible bronchoscopes after a high-level disinfection with peracetic acid: preliminary results from an Italian teaching hospital.

Troiano G, Lo Nostro A, Calonico C, Nante N, Magistri L, Pulci MB, Niccolini F.

Ann Ig. 2019 Jan-Feb;31(1):13-20. doi: 10.7416/ai.2019.2254.

3.

PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.

Niccolini F, Mencacci NE, Yousaf T, Rabiner EA, Salpietro V, Pagano G, Balint B, Efthymiou S, Houlden H, Gunn RN, Wood N, Bhatia KP, Politis M.

Mov Disord. 2018 Dec;33(12):1961-1965. doi: 10.1002/mds.27523. Epub 2018 Oct 21.

PMID:
30345538
4.

Cryptic severe Plasmodium falciparum malaria in a Moroccan man living in Tuscany, Italy, August 2018.

Zammarchi L, Di Lauria N, Bartalesi F, Suardi LR, Corti G, Mencarini J, Boccolini D, Severini C, Gradoni L, Buonamici C, Garofalo G, Bartolesi AM, Ciccone N, Berni A, Poggesi L, Niccolini F, Rossolini GM, Romi R, Bartoloni A.

Euro Surveill. 2018 Oct;23(41). doi: 10.2807/1560-7917.ES.2018.23.41.1800527.

5.

Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.

de Natale ER, Niccolini F, Wilson H, Politis M.

Int Rev Neurobiol. 2018;141:131-172. doi: 10.1016/bs.irn.2018.08.003. Epub 2018 Sep 6.

PMID:
30314595
6.

[Microbiological quality of hemodialysis water: what are the risk factors?]

Troiano G, Messina G, Zanieri E, Li Donni V, Nante N, Magisti L, Pulci MB, Niccolini F.

G Ital Nefrol. 2018 Sep;35(5). pii: 2018-vol5. Italian.

PMID:
30234238
7.

Disease-related patterns of in vivo pathology in Corticobasal syndrome.

Niccolini F, Wilson H, Hirschbichler S, Yousaf T, Pagano G, Whittington A, Caminiti SP, Erro R, Holton JL, Jaunmuktane Z, Esposito M, Martino D, Abdul A, Passchier J, Rabiner EA, Gunn RN, Bhatia KP, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2413-2425. doi: 10.1007/s00259-018-4104-2. Epub 2018 Aug 8.

8.

Applying organization science to assess the management performance of Marine Protected Areas: An exploratory study.

Scianna C, Niccolini F, Bianchi CN, Guidetti P.

J Environ Manage. 2018 Oct 1;223:175-184. doi: 10.1016/j.jenvman.2018.05.097. Epub 2018 Jun 19.

PMID:
29929073
9.

Diabetes mellitus and Parkinson disease.

Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F, Politis M.

Neurology. 2018 May 8;90(19):e1654-e1662. doi: 10.1212/WNL.0000000000005475. Epub 2018 Apr 6.

PMID:
29626177
10.

Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease.

Yousaf T, Pagano G, Niccolini F, Politis M.

J Neurol Sci. 2018 Apr 15;387:220-227. doi: 10.1016/j.jns.2018.02.032. Epub 2018 Feb 21.

PMID:
29571867
11.

Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness.

Yousaf T, Pagano G, Niccolini F, Politis M.

Sleep Med. 2018 Mar;43:25-30. doi: 10.1016/j.sleep.2017.11.1137. Epub 2017 Dec 12.

PMID:
29482807
12.

The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies.

Pagano G, Niccolini F, Politis M.

J Neural Transm (Vienna). 2018 Aug;125(8):1217-1223. doi: 10.1007/s00702-017-1823-7. Epub 2017 Dec 20. Review.

13.

Be vigilant for dementia in Parkinson’s disease.

Niccolini F, Diamantopoulos K, Kiosses S, Politis M.

Practitioner. 2017 May;261(1804):11-5. Review.

PMID:
29120562
14.

Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.

Pagano G, Yousaf T, Wilson H, Niccolini F, Polychronis S, Chaudhuri KR, Politis M.

Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.

PMID:
29078029
15.

Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies.

Niccolini F, Pagano G, Fusar-Poli P, Wood A, Mrzljak L, Sampaio C, Politis M.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):185-196. doi: 10.1136/jnnp-2017-316633. Epub 2017 Sep 9. Review.

PMID:
28889093
16.

Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer's disease.

Moonga I, Niccolini F, Wilson H, Pagano G, Politis M; Alzheimer's Disease Neuroimaging Initiative.

Eur J Neurol. 2017 Sep;24(9):1173-1182. doi: 10.1111/ene.13374. Epub 2017 Jul 28.

PMID:
28752644
17.

Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.

Niccolini F, Wilson H, Pagano G, Coello C, Mehta MA, Searle GE, Gunn RN, Rabiner EA, Foltynie T, Politis M.

Neurology. 2017 Aug 8;89(6):586-593. doi: 10.1212/WNL.0000000000004201. Epub 2017 Jul 12.

PMID:
28701494
18.

PET image reconstruction using multi-parametric anato-functional priors.

Mehranian A, Belzunce MA, Niccolini F, Politis M, Prieto C, Turkheimer F, Hammers A, Reader AJ.

Phys Med Biol. 2017 Jul 6;62(15):5975-6007. doi: 10.1088/1361-6560/aa7670.

PMID:
28570263
19.

Imaging in Parkinson's Disease.

Politis M, Pagano G, Niccolini F.

Int Rev Neurobiol. 2017;132:233-274. doi: 10.1016/bs.irn.2017.02.015. Epub 2017 Mar 30. Review.

PMID:
28554409
20.

Urinary dysfunction in early de novo patients with Parkinson's disease.

Pagano G, Niccolini F, Yousaf T, Wilson H, Polychronis S, Chaudhuri KR, Politis M.

Mov Disord. 2017 Jun;32(6):939-940. doi: 10.1002/mds.26967. Epub 2017 Mar 3. No abstract available.

PMID:
28256013
21.

Molecular Imaging Markers to Track Huntington's Disease Pathology.

Wilson H, De Micco R, Niccolini F, Politis M.

Front Neurol. 2017 Jan 30;8:11. doi: 10.3389/fneur.2017.00011. eCollection 2017. Review.

22.

Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies.

Pagano G, Niccolini F, Fusar-Poli P, Politis M.

Ann Neurol. 2017 Feb;81(2):171-180. doi: 10.1002/ana.24859. Review.

PMID:
28019672
23.

Corrigendum to "Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers" [Neurobiol. Dis. 83 (2015) 115-121].

Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, Scahill RI, Turkheimer FE, Tabrizi SJ, Piccini P.

Neurobiol Dis. 2017 Feb;98:162. doi: 10.1016/j.nbd.2016.12.003. Epub 2016 Dec 8. No abstract available.

PMID:
27939917
24.

Recommended vaccinations for asplenic and hyposplenic adult patients.

Bonanni P, Grazzini M, Niccolai G, Paolini D, Varone O, Bartoloni A, Bartalesi F, Santini MG, Baretti S, Bonito C, Zini P, Mechi MT, Niccolini F, Magistri L, Pulci MB, Boccalini S, Bechini A.

Hum Vaccin Immunother. 2017 Feb;13(2):359-368. doi: 10.1080/21645515.2017.1264797. Review.

25.

Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.

Wilson H, Niccolini F, Haider S, Marques TR, Pagano G, Coello C, Natesan S, Kapur S, Rabiner EA, Gunn RN, Tabrizi SJ, Politis M.

J Neurol Sci. 2016 Sep 15;368:243-8. doi: 10.1016/j.jns.2016.07.033. Epub 2016 Jul 15.

PMID:
27538642
26.

Imaging in Parkinson's disease.

Pagano G, Niccolini F, Politis M.

Clin Med (Lond). 2016 Aug;16(4):371-5. doi: 10.7861/clinmedicine.16-4-371. Review.

27.

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.

Niccolini F, Politis M.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2244-2254. Epub 2016 Jul 28. Review.

28.

Parkinson's Disease, Diabetes and Cognitive Impairment.

Ashraghi MR, Pagano G, Polychronis S, Niccolini F, Politis M.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):11-21. Review.

PMID:
27396477
29.

Cholinergic imaging in dementia spectrum disorders.

Roy R, Niccolini F, Pagano G, Politis M.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1376-86. doi: 10.1007/s00259-016-3349-x. Epub 2016 Mar 16. Review.

30.

Current status of PET imaging in Huntington's disease.

Pagano G, Niccolini F, Politis M.

Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1171-82. doi: 10.1007/s00259-016-3324-6. Epub 2016 Feb 22. Review.

31.

Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107.

Marques TR, Natesan S, Niccolini F, Politis M, Gunn RN, Searle GE, Howes O, Rabiner EA, Kapur S.

Am J Psychiatry. 2016 Jul 1;173(7):714-21. doi: 10.1176/appi.ajp.2015.15040518. Epub 2016 Feb 19.

32.

Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders.

Pellicano C, Niccolini F, Wu K, O'Sullivan SS, Lawrence AD, Lees AJ, Piccini P, Politis M.

J Neurol. 2015 Dec;262(12):2653-61. doi: 10.1007/s00415-015-7892-3. Epub 2015 Sep 26.

PMID:
26410743
33.

Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers.

Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, Scahill RI, Turkheimer FE, Tabrizi SJ, Piccini P.

Neurobiol Dis. 2015 Nov;83:115-21. doi: 10.1016/j.nbd.2015.08.011. Epub 2015 Aug 18.

PMID:
26297319
34.

Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.

Niccolini F, Foltynie T, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, Natesan S, Kapur S, Rabiner EA, Gunn RN, Piccini P, Politis M.

Brain. 2015 Oct;138(Pt 10):3003-15. doi: 10.1093/brain/awv219. Epub 2015 Jul 25.

35.

Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of an mgrB Deletion Mutant.

Giani T, Arena F, Vaggelli G, Conte V, Chiarelli A, Henrici De Angelis L, Fornaini R, Grazzini M, Niccolini F, Pecile P, Rossolini GM.

J Clin Microbiol. 2015 Oct;53(10):3341-4. doi: 10.1128/JCM.01017-15. Epub 2015 Jul 22.

36.

Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.

Niccolini F, Haider S, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, Natesan S, Piccini P, Kapur S, Rabiner EA, Gunn RN, Tabrizi SJ, Politis M.

Brain. 2015 Oct;138(Pt 10):3016-29. doi: 10.1093/brain/awv214. Epub 2015 Jul 21.

37.

Recent imaging advances in neurology.

Rocchi L, Niccolini F, Politis M.

J Neurol. 2015 Sep;262(9):2182-94. doi: 10.1007/s00415-015-7711-x. Epub 2015 Mar 26.

PMID:
25808503
38.

Molecular imaging of levodopa-induced dyskinesias.

Niccolini F, Rocchi L, Politis M.

Cell Mol Life Sci. 2015 Jun;72(11):2107-17. doi: 10.1007/s00018-015-1854-x. Epub 2015 Feb 15. Review.

PMID:
25681866
39.

A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012.

Bechini A, Taddei C, Barchielli A, Levi M, Tiscione E, Santini MG, Niccolini F, Mechi MT, Panatto D, Amicizia D, Azzari C, Bonanni P, Boccalini S.

Hum Vaccin Immunother. 2015;11(1):156-65. doi: 10.4161/hv.34418. Epub 2014 Nov 1.

40.

Serotonin in Parkinson's disease.

Politis M, Niccolini F.

Behav Brain Res. 2015 Jan 15;277:136-45. doi: 10.1016/j.bbr.2014.07.037. Epub 2014 Jul 31. Review.

PMID:
25086269
41.

Neuroimaging in Huntington's disease.

Niccolini F, Politis M.

World J Radiol. 2014 Jun 28;6(6):301-12. doi: 10.4329/wjr.v6.i6.301. Review.

42.

Dopamine receptor mapping with PET imaging in Parkinson's disease.

Niccolini F, Su P, Politis M.

J Neurol. 2014 Dec;261(12):2251-63. doi: 10.1007/s00415-014-7302-2. Epub 2014 Mar 15. Review.

PMID:
24627109
43.

PET in multiple sclerosis.

Niccolini F, Su P, Politis M.

Clin Nucl Med. 2015 Jan;40(1):e46-52. doi: 10.1097/RLU.0000000000000359. Review.

PMID:
24561681
44.

The effect of leadership on hand hygiene: assessing hand hygiene adherence prior to patient contact in 2 infectious disease units in Tuscany.

Lieber SR, Mantengoli E, Saint S, Fowler KE, Fumagalli C, Bartolozzi D, Magistri L, Niccolini F, Bartoloni A.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):313-6. doi: 10.1086/675296. Epub 2014 Jan 31.

PMID:
24521600
45.

Dyskinesias in Parkinson's disease: views from positron emission tomography studies.

Niccolini F, Loane C, Politis M.

Eur J Neurol. 2014 May;21(5):694-9, e39-43. doi: 10.1111/ene.12362. Epub 2014 Jan 28. Review.

PMID:
24471508
46.

A queueing theory based model for business continuity in hospitals.

Miniati R, Cecconi G, Dori F, Frosini F, Iadanza E, Biffi Gentili G, Niccolini F, Gusinu R.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:922-5. doi: 10.1109/EMBC.2013.6609652.

PMID:
24109839
47.

HTA decision support system for sustainable business continuity management in hospitals. The case of surgical activity at the University Hospital in Florence.

Miniati R, Dori F, Cecconi G, Gusinu R, Niccolini F, Gentili GB.

Technol Health Care. 2013;21(1):49-61. doi: 10.3233/THC-120709.

PMID:
23358059
48.

Patients' evaluation of hospital foodservice quality in Italy: what do patients really value?

Messina G, Fenucci R, Vencia F, Niccolini F, Quercioli C, Nante N.

Public Health Nutr. 2013 Apr;16(4):730-7. doi: 10.1017/S1368980012003333. Epub 2012 Aug 8.

PMID:
22874795
49.

A methodology aimed to guarantee technology continuity in health structures.

Miniati R, Dori F, Iadanza E, Scatizzi L, Niccolini F, Sarti A.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:1213-6. doi: 10.1109/IEMBS.2011.6090285.

PMID:
22254534

Supplemental Content

Loading ...
Support Center